Depression is Real. You’re Not Alone.

Recent data shows:

• In the U.S. about 13% of people ages 12 and older experienced depression symptoms in a recent two-week period — with adolescents showing the highest rates.

• Nearly 1 in 5 U.S. adults report having been diagnosed with depression at some point in their lives.

• Globally, an estimated 5.7% of adults live with depression — making it one of the most common mental health conditions worldwide.

Depression doesn’t discriminate — it can affect youth, adults, and seniors, impacting daily life, relationships, motivation, sleep, and overall joy. But here’s the most important part:

Depression is treatable — and there are real paths to hope.

Medication Management: Traditional antidepressants continue to help many people regain balance when monitored carefully by a clinician.

TMS (Transcranial Magnetic Stimulation): A non-invasive therapy that uses magnetic pulses to gently stimulate areas of the brain involved in mood regulation — often effective for those who haven’t responded to medications.

SPRAVATO® (Esketamine): A breakthrough nasal treatment for treatment-resistant depression with rapid effects for many patients.

IV Ketamine Therapy: A fast-acting option shown in research to produce significant relief and remission for many people when combined with clinical support and therapy.

What You Can Do Right Now

•  Talk with someone you trust
• Reach out to a mental health professional
• Practice small self-care routines
• If your are in crisis, contact local emergency services or crisis hotline
• 988 Lifeline

 
 If you’re in crisis, contact local emergency services or a crisis hotline

You are not alone. There are treatment options that work.
Let’s keep the conversation growing — ❤️ share this message to help someone today.

#MentalHealthMatters #DepressionAwareness #YouAreNotAlone #HopeAndHealing

Sources & References

• Centers for Disease Control and Prevention (CDC).
  Depression affects millions of adults and adolescents in the United States, with rising rates among youth and young adults.
  https://www.cdc.gov/nchs/products/databriefs/db527.htm

• Centers for Disease Control and Prevention (CDC).
  Overview of depression prevalence, diagnosis, and treatment in U.S. adults.
  https://www.cdc.gov/mental-health/about-data/conditions-care.html

• World Health Organization (WHO).
  Depression is a common mental health condition worldwide and is considered treatable with appropriate care.
  https://www.who.int/news-room/fact-sheets/detail/depression

• National Institute of Mental Health (NIMH).
  Evidence-based overview of brain stimulation therapies, including Transcranial Magnetic Stimulation (TMS).
  https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies

• JAMA Psychiatry.
  Clinical research supporting the effectiveness of SPRAVATO® (esketamine) for treatment-resistant depression.
  https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2733654

• National Institutes of Health / Neuron Journal.
  Research demonstrating the antidepressant effects of ketamine therapies when administered in a clinical setting.
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767816/